Essen, Germany. Evonik hereby announces a net price increase of 10% for MetAMINO® (DL-methionine 99%, feed grade), effective immediately for all markets.
All existing contracts and supply agreements will be honored.
Evonik: Leading beyond chemistry
Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.
About Advanced Technologies
The Advanced Technologies segment includes Evonik’s market-leading businesses that leverage technological expertise and process know-how. These businesses feature high-performance polymers and crosslinking agents, hydrogen peroxide and silica, as well as feed ingredients. In 2025, the segment generated sales of €5.9 billion with around 9,200 employees.
Disclaimer
In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
Evonik Industries AG
Rellinghauser Straße 1-11
45128 Essen
Germany
Phone +49 201 177-01
www.evonik.com
Supervisory Board Bernd Tönjes, Chairman Executive Board Christian Kullmann, Lauren Kjeldsen, Dr. Claudine Mollenkopf, Thomas Wessel
Registered Office is Essen Register Court Essen Local Court Commercial Registry B 19474
